**15. Final considerations of the results**

The efficacy of immunotherapy is certainly higher in children, as it is confirmed by a lower number of surgical interventions and by the stabilisation and healing results. *We analysed 50 cases of hematogenous osteomyelitis in order to consider which factors might have influenced the prognoses.*


that has been lasted more than 1 year. Immunotherapy has to be started as soon as possible.

*Another analysis with similar considerations has been made by us on 147 cases of infected pseudoarthrose*:

